Pt. no. | Sex | Age at onset | Total follow-up perioda, months | Total relapse timea | FR | Biopsy | Sampling age at rel | Relapse times at sampling | Intervalsb, weeks | PSL at relc mg/day | PLS at remc mg/d | IS at relc mg/day | IS at remc mg/day | CD14+, n = 6 | RO−, n = 4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 10 years, 4 months | 96 | 6 | Yes | MC | 13 years, 0 months | 3rd | 5 | 40 | 10 | 0 | 0 | Taken | Taken |
2 | M | 5 years, 4 months | 53 | 6 | Yes | MC | 6 years, 0 months | 3rd | 16 | 0 | 35 | 0 | CyA90 | Taken | Taken |
3 | M | 5 years, 11 months | 204 | 11 | Yes | MC | 18 years, 6 months | 9th | 23 | 10 | 15 | 0 | 0 | Taken | Taken |
4 | M | 7 years, 3 months | 192 | 15 | Yes | MC | 19 years, 10 months | 13th | 23 | 60 | 5 | 0 | 0 | Taken | Taken |
5 | M | 9 years, 9 months | 109 | 4 | Yes | ND | 11 years, 7 months | 4th | 12 | 0 | 0 | CyA180 | CyA160 | Taken | NT |
6 | M | 11 years, 11 months | 79 | 8 | Yes | ND | 12 years, 5 months | 4th | 71 | 0 | 20 | MZV125 | MZV 75 | Taken | NT |
Mean | 8 years, 4 months | 122.2 | 8.3 | 13 years, 5 months | 6th | 25 |